Philippe Latry

631 total citations
15 papers, 461 citations indexed

About

Philippe Latry is a scholar working on Family Practice, Economics and Econometrics and Surgery. According to data from OpenAlex, Philippe Latry has authored 15 papers receiving a total of 461 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Family Practice, 5 papers in Economics and Econometrics and 2 papers in Surgery. Recurrent topics in Philippe Latry's work include Medication Adherence and Compliance (6 papers), Pharmaceutical Economics and Policy (5 papers) and Climate Change and Health Impacts (2 papers). Philippe Latry is often cited by papers focused on Medication Adherence and Compliance (6 papers), Pharmaceutical Economics and Policy (5 papers) and Climate Change and Health Impacts (2 papers). Philippe Latry collaborates with scholars based in France, Belize and Japan. Philippe Latry's co-authors include Karin Martin‐Latry, Bernard Bégaud, Bernard Bégaud, Hélène Verdoux, Mathiéu Molimard, Nicholas Moore, A Fourrier, Ghada Miremont‐Salamé, I. Faure and C. Gabinski and has published in prestigious journals such as Acta Psychiatrica Scandinavica, British Journal of Clinical Pharmacology and American Journal of Geriatric Psychiatry.

In The Last Decade

Philippe Latry

15 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Philippe Latry France 9 137 124 90 70 64 15 461
Karin Martin‐Latry France 9 137 1.0× 126 1.0× 77 0.9× 82 1.2× 61 1.0× 16 467
Adele Lallo Italy 9 241 1.8× 66 0.5× 50 0.6× 89 1.3× 33 0.5× 12 481
Sébastien Chanoine France 14 30 0.2× 143 1.2× 47 0.5× 24 0.3× 146 2.3× 51 471
Wendy Kennedy Canada 13 39 0.3× 71 0.6× 124 1.4× 65 0.9× 28 0.4× 23 611
Omar Thanoon Dawood Malaysia 12 86 0.6× 37 0.3× 13 0.1× 57 0.8× 46 0.7× 32 530
Babak Aliarzadeh Canada 13 31 0.2× 30 0.2× 42 0.5× 122 1.7× 32 0.5× 43 496
Augustine Lam Hong Kong 9 64 0.5× 24 0.2× 19 0.2× 29 0.4× 39 0.6× 17 366
Amal Al‐Hajje Lebanon 15 20 0.1× 47 0.4× 62 0.7× 29 0.4× 161 2.5× 53 562
Lisa Cohen United States 12 20 0.1× 58 0.5× 46 0.5× 126 1.8× 202 3.2× 28 628
L T W de Jong-van den Berg Netherlands 13 25 0.2× 29 0.2× 37 0.4× 63 0.9× 97 1.5× 24 670

Countries citing papers authored by Philippe Latry

Since Specialization
Citations

This map shows the geographic impact of Philippe Latry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philippe Latry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philippe Latry more than expected).

Fields of papers citing papers by Philippe Latry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Philippe Latry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philippe Latry. The network helps show where Philippe Latry may publish in the future.

Co-authorship network of co-authors of Philippe Latry

This figure shows the co-authorship network connecting the top 25 collaborators of Philippe Latry. A scholar is included among the top collaborators of Philippe Latry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Philippe Latry. Philippe Latry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Martin‐Latry, Karin, et al.. (2022). One-year care pathway after acute myocardial infarction in 2018: Prescription, medical care and medication adherence, using a French health insurance reimbursement database. Archives of cardiovascular diseases. 115(2). 78–86. 5 indexed citations
2.
Martin‐Latry, Karin, et al.. (2020). Validation d’une échelle de mesure de l’adhésion médicamenteuse cardiovasculaire utilisable en contexte hospitalier. Annales Pharmaceutiques Françaises. 79(4). 457–464. 1 indexed citations
3.
4.
Latry, Philippe, et al.. (2011). Adherence with statins in a real-life setting is better when associated cardiovascular risk factors increase: a cohort study. BMC Cardiovascular Disorders. 11(1). 46–46. 44 indexed citations
5.
6.
Latry, Philippe, Mathiéu Molimard, Bernard Bégaud, & Karin Martin‐Latry. (2010). How reimbursement databases can be used to support drug utilisation studies: example using the main French national health insurance system database. European Journal of Clinical Pharmacology. 66(7). 743–748. 29 indexed citations
7.
Nordon, Clémentine, Karin Martin‐Latry, Philippe Latry, et al.. (2009). Risk of Death Related to Psychotropic Drug Use in Older People During the European 2003 Heatwave: A Population-Based Case–Control Study. American Journal of Geriatric Psychiatry. 17(12). 1059–1067. 31 indexed citations
8.
Latry, Philippe, et al.. (2008). Adherence to anti-inflammatory treatment for asthma in clinical practice in France. Clinical Therapeutics. 30. 1058–1068. 50 indexed citations
9.
Martin‐Latry, Karin, Philippe Latry, C. Gabinski, et al.. (2007). Psychotropic drugs use and risk of heat-related hospitalisation. European Psychiatry. 22(6). 335–338. 122 indexed citations
10.
Martin‐Guehl, Corinne, Nathalie Lechevallier‐Michel, Pernelle Noïze, et al.. (2006). Use of psychotropic drugs in 0 to 5 years old children in Aquitaine (France): prevalence and associated factors. Pharmacoepidemiology and Drug Safety. 15(7). 504–509. 7 indexed citations
11.
12.
Bégaud, Bernard, et al.. (2004). Patterns of risperidone prescription: a utilization study in south‐west France. Acta Psychiatrica Scandinavica. 109(3). 202–206. 15 indexed citations
13.
Bégaud, Bernard, et al.. (2003). Differences between clinical trials and postmarketing use. British Journal of Clinical Pharmacology. 57(1). 86–92. 113 indexed citations
14.
Latry, Philippe, et al.. (2000). [Impact of demographic changes on drug utilization related to diabetes in Aquitaine].. PubMed. 39(2-3). 253–69. 2 indexed citations
15.
Quinton, A, Philippe Latry, & M Biour. (1993). [Hepatox: database on hepatotoxic drugs].. PubMed. 17(5 Pt 2). H116–20. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Karin Martin‐Latry Breakdown of academic impact, for papers by Adele Lallo Breakdown of academic impact, for papers by Sébastien Chanoine Breakdown of academic impact, for papers by Wendy Kennedy Breakdown of academic impact, for papers by Omar Thanoon Dawood Breakdown of academic impact, for papers by Babak Aliarzadeh Breakdown of academic impact, for papers by Augustine Lam Breakdown of academic impact, for papers by Amal Al‐Hajje Breakdown of academic impact, for papers by Lisa Cohen Breakdown of academic impact, for papers by L T W de Jong-van den Berg
Rankless by CCL
2026